Xue Zhang
Research Associate at Stanford University
Data updated
Research Footprint
Xue Zhang appears in 5 tracked papers (2014–2026), most studied alongside Psilocybin, Placebo and Ketamine, across Neuroimaging & Brain Measures, Depressive Disorders and Healthy Volunteers.
Most-cited paper: Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia (63 citations).
Frequent co-authors: Luke Williams, Laura Michele Hack and Boris Heifets.
Background & Research
Xue Zhang is a researcher at Stanford University whose publications focus on ketamine, MDMA, and related mechanisms of altered states of consciousness, affect, and neural circuitry in humans. Her coauthored work includes mechanistic clinical and neuroimaging studies in psychiatric and psychedelic science, including ketamine effects on negative brain states and MDMA responses in affective circuit subtypes.
Key Impact
Her work helps explain how ketamine and MDMA alter brain state, consciousness, and emotional processing in humans, which is directly relevant to psychedelic- and psychopharmacology-focused psychiatric research.
Collaboration Network
14 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Xue Zhang is associated with.